Effects of abatacept (Orencia) on biomarkers in synovial tissue in patients with rheumatoid arthritis.
Phase of Trial: Phase IV
Latest Information Update: 28 Nov 2017
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Biomarker; Therapeutic Use
- 10 May 2011 Additional lead trial centre identified as reported by European Clinical Trials Database record.
- 10 May 2011 New source identified and integrated (European Clinical Trials Database record EudraCT2010-021435-14).
- 14 Dec 2010 New trial record